S-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats

A. B. Seabra, E. Pankotai, M. Fehér, Á Somlai, L. Kiss, L. Bíró, Csaba Szabo, M. Kollai, M. G. De Oliveira, Z. Lacza

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background: Endothelial dysfunction is characterized by decreased vasodilatory capacity of the arterioles mainly due to the reduced release of nitric oxide (NO). Application of NO donors may prevent or even reverse the consequences of endothelial dysfunction, such as diabetic leg ulcers. Objectives: To investigate the vasodilatory capacity and the possible side-effects of topical application of an NO donor-containing hydrogel in diabetic rats. Methods: S-nitrosoglutathione (GSNO) was incorporated in Pluronic® F127 hydrogel and applied on the foot sole skin of healthy and streptozotocin-induced diabetic rats. Blood flow was monitored using a laser-Doppler probe. Nitrotyrosine formation, a possible side-effect of GSNO action, was evaluated by Western blotting of skin protein extracts. Systemic circulatory side-effects were investigated by monitoring blood pressure and heart rate during the application. Results: The hydrogel alone did not induce any changes in microvascular flow, while GSNO-containing hydrogel caused a twofold increase in perfusion. This effect was similar in diabetic and healthy animals. Topical GSNO application did not increase the nitrotyrosine content of skin proteins, nor did it have any effect on blood pressure or heart rate. Conclusions: Dermal application of GSNO may be an effective treatment for promoting the local vasodilation in both healthy and diabetic states, without inducing protein nitration or alterations in blood pressure or heart rate.

Original languageEnglish (US)
Pages (from-to)814-818
Number of pages5
JournalBritish Journal of Dermatology
Volume156
Issue number5
DOIs
StatePublished - May 2007
Externally publishedYes

Fingerprint

S-Nitrosoglutathione
Hydrogel
Streptozocin
Skin
UCON 50-HB-5100
Nitric Oxide Donors
Heart Rate
Blood Pressure
Poloxamer
Leg Ulcer
Proteins
Arterioles
Vasodilation
Foot
Nitric Oxide
Lasers
Perfusion
Western Blotting

Keywords

  • Dermal microcirculation
  • Diabetes
  • Hydrogel
  • Laser-Doppler
  • Nitric oxide
  • Topical application

ASJC Scopus subject areas

  • Dermatology

Cite this

S-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats. / Seabra, A. B.; Pankotai, E.; Fehér, M.; Somlai, Á; Kiss, L.; Bíró, L.; Szabo, Csaba; Kollai, M.; De Oliveira, M. G.; Lacza, Z.

In: British Journal of Dermatology, Vol. 156, No. 5, 05.2007, p. 814-818.

Research output: Contribution to journalArticle

Seabra, AB, Pankotai, E, Fehér, M, Somlai, Á, Kiss, L, Bíró, L, Szabo, C, Kollai, M, De Oliveira, MG & Lacza, Z 2007, 'S-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats', British Journal of Dermatology, vol. 156, no. 5, pp. 814-818. https://doi.org/10.1111/j.1365-2133.2006.07718.x
Seabra, A. B. ; Pankotai, E. ; Fehér, M. ; Somlai, Á ; Kiss, L. ; Bíró, L. ; Szabo, Csaba ; Kollai, M. ; De Oliveira, M. G. ; Lacza, Z. / S-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats. In: British Journal of Dermatology. 2007 ; Vol. 156, No. 5. pp. 814-818.
@article{ef1e028a6d53411cb673c857318b2186,
title = "S-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats",
abstract = "Background: Endothelial dysfunction is characterized by decreased vasodilatory capacity of the arterioles mainly due to the reduced release of nitric oxide (NO). Application of NO donors may prevent or even reverse the consequences of endothelial dysfunction, such as diabetic leg ulcers. Objectives: To investigate the vasodilatory capacity and the possible side-effects of topical application of an NO donor-containing hydrogel in diabetic rats. Methods: S-nitrosoglutathione (GSNO) was incorporated in Pluronic{\circledR} F127 hydrogel and applied on the foot sole skin of healthy and streptozotocin-induced diabetic rats. Blood flow was monitored using a laser-Doppler probe. Nitrotyrosine formation, a possible side-effect of GSNO action, was evaluated by Western blotting of skin protein extracts. Systemic circulatory side-effects were investigated by monitoring blood pressure and heart rate during the application. Results: The hydrogel alone did not induce any changes in microvascular flow, while GSNO-containing hydrogel caused a twofold increase in perfusion. This effect was similar in diabetic and healthy animals. Topical GSNO application did not increase the nitrotyrosine content of skin proteins, nor did it have any effect on blood pressure or heart rate. Conclusions: Dermal application of GSNO may be an effective treatment for promoting the local vasodilation in both healthy and diabetic states, without inducing protein nitration or alterations in blood pressure or heart rate.",
keywords = "Dermal microcirculation, Diabetes, Hydrogel, Laser-Doppler, Nitric oxide, Topical application",
author = "Seabra, {A. B.} and E. Pankotai and M. Feh{\'e}r and {\'A} Somlai and L. Kiss and L. B{\'i}r{\'o} and Csaba Szabo and M. Kollai and {De Oliveira}, {M. G.} and Z. Lacza",
year = "2007",
month = "5",
doi = "10.1111/j.1365-2133.2006.07718.x",
language = "English (US)",
volume = "156",
pages = "814--818",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - S-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats

AU - Seabra, A. B.

AU - Pankotai, E.

AU - Fehér, M.

AU - Somlai, Á

AU - Kiss, L.

AU - Bíró, L.

AU - Szabo, Csaba

AU - Kollai, M.

AU - De Oliveira, M. G.

AU - Lacza, Z.

PY - 2007/5

Y1 - 2007/5

N2 - Background: Endothelial dysfunction is characterized by decreased vasodilatory capacity of the arterioles mainly due to the reduced release of nitric oxide (NO). Application of NO donors may prevent or even reverse the consequences of endothelial dysfunction, such as diabetic leg ulcers. Objectives: To investigate the vasodilatory capacity and the possible side-effects of topical application of an NO donor-containing hydrogel in diabetic rats. Methods: S-nitrosoglutathione (GSNO) was incorporated in Pluronic® F127 hydrogel and applied on the foot sole skin of healthy and streptozotocin-induced diabetic rats. Blood flow was monitored using a laser-Doppler probe. Nitrotyrosine formation, a possible side-effect of GSNO action, was evaluated by Western blotting of skin protein extracts. Systemic circulatory side-effects were investigated by monitoring blood pressure and heart rate during the application. Results: The hydrogel alone did not induce any changes in microvascular flow, while GSNO-containing hydrogel caused a twofold increase in perfusion. This effect was similar in diabetic and healthy animals. Topical GSNO application did not increase the nitrotyrosine content of skin proteins, nor did it have any effect on blood pressure or heart rate. Conclusions: Dermal application of GSNO may be an effective treatment for promoting the local vasodilation in both healthy and diabetic states, without inducing protein nitration or alterations in blood pressure or heart rate.

AB - Background: Endothelial dysfunction is characterized by decreased vasodilatory capacity of the arterioles mainly due to the reduced release of nitric oxide (NO). Application of NO donors may prevent or even reverse the consequences of endothelial dysfunction, such as diabetic leg ulcers. Objectives: To investigate the vasodilatory capacity and the possible side-effects of topical application of an NO donor-containing hydrogel in diabetic rats. Methods: S-nitrosoglutathione (GSNO) was incorporated in Pluronic® F127 hydrogel and applied on the foot sole skin of healthy and streptozotocin-induced diabetic rats. Blood flow was monitored using a laser-Doppler probe. Nitrotyrosine formation, a possible side-effect of GSNO action, was evaluated by Western blotting of skin protein extracts. Systemic circulatory side-effects were investigated by monitoring blood pressure and heart rate during the application. Results: The hydrogel alone did not induce any changes in microvascular flow, while GSNO-containing hydrogel caused a twofold increase in perfusion. This effect was similar in diabetic and healthy animals. Topical GSNO application did not increase the nitrotyrosine content of skin proteins, nor did it have any effect on blood pressure or heart rate. Conclusions: Dermal application of GSNO may be an effective treatment for promoting the local vasodilation in both healthy and diabetic states, without inducing protein nitration or alterations in blood pressure or heart rate.

KW - Dermal microcirculation

KW - Diabetes

KW - Hydrogel

KW - Laser-Doppler

KW - Nitric oxide

KW - Topical application

UR - http://www.scopus.com/inward/record.url?scp=34247348224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247348224&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2133.2006.07718.x

DO - 10.1111/j.1365-2133.2006.07718.x

M3 - Article

C2 - 17263816

AN - SCOPUS:34247348224

VL - 156

SP - 814

EP - 818

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 5

ER -